A distinctive feature of autogenous vaccines is that each vaccine batch is unique. In addition, autogenous vaccines are exempt from marketing authorisation requirements (in Europe). This means that no specific safety and efficacy tests are performed for each individual batch. The tolerability of autogenous vaccines is influenced by a wide range of factors. The antigens […]
